abstract |
A pharmaceutical agent comprising a salt of 3 - {(2S, 4S) -4- [4- (3-methyl-1-phenyl-1H-pyrazol-5-yl) piperazin-1-yl] pyrrolidin-2-ylcarbonyl } Thiazolidine with 2.0 hydrobromic acid, 2.5 hydrobromic acid, 2 maleic acid, 2 tosylic acid, 2.5 hydrochloric acid, 2 naphthalen-1-sulfonic acid, 2 mesyl acid, 3 mesyl acid or 2 naphthalen-2 acid -sulfonic, or one of its solvates, for use in the prophylaxis and / or treatment of postprandial hyperlipidemia |